Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

pertuzumab

- PMLiVE

UK NHS reforms create £20bn opportunity for private sector

Report from Catalyst says NHS reforms pave way for healthcare companies

- PMLiVE

UK hospitals cannot cope with demand says RCP

Report claims acute care on “brink of collapse”

- PMLiVE

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

- PMLiVE

Roche loses Indian Tarceva patent battle with Cipla

As Novartis' Glivec patent law challenge begins again

- PMLiVE

GSK persuades NICE to reconsider negative Benlysta decision

Decision on lupus drug referred to expert committee following appeal

- PMLiVE

NHS social network How Are You? launches UK’s first health app store

A partnership with Cambridge Healthcare, the network's store offers easy access to health apps

- PMLiVE

Scottish cabinet reshuffle sees Alex Neil made health secretary

Moves from infrastructure, investment and cities to take over from Nicola Sturgeon

Roche - Basel

Roche says pipeline will balance cancer drug patent losses

Has 11 new molecular entities in late-stage portfolio and 11 line extensions

Jeremy Hunt replaces Andrew Lansley as UK Health Secretary

Will take over implementation of NHS reforms and efficiency savings

- PMLiVE

UK sets up digital innovation fund to improve patient care

NHS fund will also support new services that help share healthcare information

- PMLiVE

UK pharma ‘must prove value’ to the NHS

Facing unprecedented financial pressures, it is imperative companies continue to evolve

- PMLiVE

New cancer drugs safer for patients, says study

NHS and research charity sees huge benefits in targeted cancer therapies

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links